FORT WAYNE, IN – BioPoly LLC has announced that another U.S. patent has been granted for its partial resurfacing implants. Where many of the other BioPoly® patents address the unique material, this patent family focuses on the innovative implant designs. With BioPoly’s recent approval from the FDA to begin an IDE Clinical study in the US for its BioPoly RS Partial Resurfacing Knee implant, this most recent patent, entitled “Partial joint resurfacing implant, instrumentation, and method”, adds to the Company’s intellectual property portfolio to provide the assurance that all aspects of the implants, material, and surgical technique are protected throughout [...]

FORT WAYNE, IN – BioPoly, LLC has entered into an exclusive distribution agreement with UK-based distributor, Hospital Innovations Ltd, to distribute the BioPoly® partial resurfacing family of products throughout the UK.  Hospital Innovations, founded in 2008, supplies a growing range of specialty products for use in orthopaedic and corrective surgery.  Herb Schwartz, BioPoly President, said “We at BioPoly are very excited to be partnering with Hospital Innovations in the UK. Their knowledgeable and experienced team will represent BioPoly’s growing product portfolio very well as they expand the market and provide the best service to the UK orthopaedic surgeon customers.” BioPoly [...]

FORT WAYNE, IN – BioPoly LLC has announced that another European patent has been granted for its partial resurfacing implants. Where many of the other BioPoly® patents address the unique material, this patent family focuses on the innovative implant designs. With four product lines that are now regulatory approved (i.e. CE marked) in Europe, receiving additional intellectual property protection in European countries is an important part of the Company’s overall risk management plan. With BioPoly’s recent announcement that it received FDA approval to begin an IDE Clinical study in the US with its BioPoly RS Partial Resurfacing Knee implant, the [...]

FORT WAYNE, IN – BioPoly has just announced that the US FDA has approved an IDE clinical study for its BioPoly® RS Partial Resurfacing Knee System. The BioPoly knee is used to treat patients with painful cartilage lesions by filling the defect with its proprietary implant material known as BioPoly. According to the Company, initiation of the clinical study in the US will happen soon. The BioPoly material is comprised of a robust polymer and a biological lubricating molecule (hyaluronic acid) that is found in joint fluid. This combination creates a “self-lubricated” polymer that can carry physiological loads in the knee without [...]